Federal health officials are now scrambling to fix tech issues, first reported by The Washington Post, that are displaying inaccuracies in the new online directory for Medicare Advantage plans on the ...

This analysis reviews the history and current status of biosimilar regulation in the US, concluding that changing the FDA’s interchangeability standards—as proposed by some policy makers—is a ...

Dishonest businesses sometimes misrepresent medical discount plans as health insurance plans or a substitute for traditional health insurance. If a plan claims to offer unusually high discounts or is ...